Copley Acquisition Corp (COPL)

Form 8-K - Current report

Copley Acquisition Corp (NYSE: COPL) and Ignite Proteomics Announce Business Combination Agreement to Advance Precision Oncology

Ignite Proteomics is a pioneer in delivering pathway-level protein analytics designed to guide precision oncology. HONG KONG, June 11, 2026...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Copley Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing on or about June 2, 2025

HONG KONG, May 22, 2025 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPLU) (the “Company”) announced that holders of the units sold in...

Copley Acquisition Corp Announces Closing of $172,500,000 Initial Public Offering

HONG KONG, May 02, 2025 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPLU) (the “Company”) today announced that it closed its initial...

Copley Acquisition Corp Announces Pricing of $150,000,000 Initial Public Offering

HONG KONG, April 30, 2025 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPLU) (the “Company”) announced today the pricing of its initial...